Patents by Inventor Matthias Manne Knopp

Matthias Manne Knopp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATION
    Publication number: 20230190685
    Abstract: The invention relates to formulations comprising a halogenated salicylanilide, or a pharmaceutically acceptable salt thereof, and a cyclodextrin. The formulations may be in the form of a liquid formulation, particularly an aqueous formulation, and provide high concentrations of solubilised halogenated salicylanilide. Also disclosed a formulations in the form of powders and aerosols. Also disclosed are the formulations for use in the treatment of bacterial and viral infections, and the treatment of inflammatory diseases. The formulations are particularly suitable for administration by inhalation for the treatment of bacterial and viral pulmonary infections and the treatment of pulmonary inflammatory diseases.
    Type: Application
    Filed: March 26, 2021
    Publication date: June 22, 2023
    Inventors: Morten SOMMER, Rasmus TOFT-KEHLER, Anne Katrine TOFT-KEHLER, Günter DITZINGER, Mads JELLINGSOE, Philippe ANDRES, Matthias Manne KNOPP
  • Niclosamide formulations for treating disease
    Patent number: 11324708
    Abstract: The invention relates to a method of treating a viral infection caused by or associated with SARS-CoV-2 in a subject, the method comprising administering to the subject by inhalation intraorally and/or intranasally a therapeutically effective amount of a formulation comprising niclosamide, or a pharmaceutically acceptable salt thereof, and a cyclodextrin.
    Type: Grant
    Filed: May 25, 2021
    Date of Patent: May 10, 2022
    Assignee: UNION therapeutics A/S
    Inventors: Morten Otto Alexander Sommer, Rasmus Toft-Kehler, Anne Katrine Toft-Kehler, Günter Ditzinger, Mads Jellingsoe, Philippe Andres, Matthias Manne Knopp
  • AMORPHOUS COMPOUNDS OF FORMULA (I) AND AMORPHOUS COMPOUNDS OF FORMULA (I) SALTS
    Publication number: 20210395208
    Abstract: The present invention relates to compositions comprising amorphous compounds of Formula (I) or amorphous compounds of Formula (I) salts and to processes for obtaining these. In particular, the invention relates to compositions comprising amorphous compounds of Formula (I) hydrogen fumarate and to processes for obtaining this. Further, the invention also relates to compositions comprising amorphous base of compounds of Formula (I) and to processes for obtaining this. The invention also relates to pharmaceutical compositions comprising amorphous compounds of Formula (I) or amorphous compounds of Formula (I) salts for treatment of psychiatric disorders such as schizophrenia, including Treatment Resistant Schizophrenia (TRS).
    Type: Application
    Filed: October 28, 2019
    Publication date: December 23, 2021
    Applicant: H. Lundeck A/S
    Inventors: Jens Kateb, Matthias Manne Knopp
  • Niclosamide formulations for treating disease
    Patent number: 11045434
    Abstract: The invention relates to a method of treating a viral infection caused by or associated with SARS-CoV-2 in a subject, the method comprising administering to the subject by inhalation intraorally and/or intranasally a therapeutically effective amount of a formulation comprising niclosamide, or a pharmaceutically acceptable salt thereof, and a cyclodextrin.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: June 29, 2021
    Assignee: UNION therapeutics A/S
    Inventors: Morten Otto Alexander Sommer, Rasmus Toft-Kehler, Anne Katrine Toft-Kehler, Günter Ditzinger, Mads Jellingsoe, Philippe Andres, Matthias Manne Knopp